Возраст домена | 13 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | n/a |
Страниц в Google | 12 |
Страниц в Яндексе | 6 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 22631109 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
CAPRELSA® (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma (MTC)
medullary thyroid cancer treatment, CAPRELSA, vandetanib, medullary thyroid cancer, unresectable locally advanced medullary thyroid cancer, metastatic medullary thyroid cancer, caprelsarems.com
Information for the CAPRELSA REMS Program. CAPRELSA® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced or metastatic disease.
UTF-8
16.08 КБ
360
2 975 симв.
2 549 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
fda.gov | 14 | 8 |
1000 | 4981 | 1747 | |
er-la-opioidrems.com | 12 | 5 |
0 | 7149534 | Нет данных | |
nccn.org | 8 | 7 |
90 | 76919 | 21838 | |
ashp.org | 8 | 7 |
20 | 88771 | 18336 | |
tirfremsaccess.com | 7 | 5 |
0 | 3405018 | 451819 | |
paragonrx.com | 6 | 2 |
0 | 6456406 | Нет данных | |
ons.org | 5 | 7 |
0 | 251482 | 83245 | |
mckesson.com | 5 | 6 |
0 | 25526 | 4662 | |
covance.com | 5 | 6 |
0 | 120288 | 38518 | |
yervoy.com | 5 | n/a | 0 | 2893760 | 630104 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 25 Августа 2013 ) | |
Количество ссылок на сайт | 6 |
Количество доменов, которые ссылаются на сайт | 6 |
Количество найденных анкоров | 5 |
Исходящие (внешние) ссылки домена | 0 |
Количество доменов, на которые ссылается сайт | 0 |
Количество исходящих анкоров | 0 |
Внешние ссылки главной страницы ( 6 ) | |
new-enrollment.com/ | Enroll |
sanofigenzyme.com/ | <img> |
fda.gov/medwatch | www.FDA.gov/medwatch |
sanofigenzyme.com/privacy-policy.aspx | Privacy Notice |
sanofigenzyme.com/Terms-Of-Use.aspx | Legal Terms and Conditions |
sanofigenzyme.com | Genzyme Corporation |
Внутренние ссылки главной страницы ( 8 ) | |
/index.asp# | Print Page |
/files/caprelsa-pi.pdf?v=2.0 | Prescribing Information |
/files/caprelsa-prescription-form.pdf | Form |
/files/caprelsa-rems-patient-brochure.pdf | Brochure |
/education.asp | Educational Materials |
/learn.asp | Learn About the CAPRELSA REMS Program |
/contactus.asp | Contact Us |
/sitemap.asp | Site Map |
[Querying whois.verisign-grs.com]
[Redirected to whois.corporatedomains.com]
[Querying whois.corporatedomains.com]
[whois.corporatedomains.com]
Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.
Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.
NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. CSC does not guarantee its accuracy. By submitting a WHOIS query, you agree to abide by the following terms of use: you agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via direct mail, e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to CSC (or its computer systems). CSC reserves the right to terminate your access to the WHOIS database in its sole discretion for any violations by you of these terms of use. CSC reserves the right to modify these terms at any time.
Registrant:
AstraZeneca AB
Domains Administration
Vastra Malarehamnen 9
Sodertalje, 15185
SE
Email: domains@astrazeneca.com
Registrar Name....: CORPORATE DOMAINS, INC.
Registrar Whois...: whois.corporatedomains.com
Registrar Homepage: www.cscprotectsbrands.com
Domain Name: caprelsarems.com
Created on..............: Wed, Feb 16, 2011
Expires on..............: Sun, Feb 16, 2014
Record last updated on..: Wed, Mar 07, 2012
Administrative Contact:
AstraZeneca AB
Domains Administration
Vastra Malarehamnen 9
Sodertalje, 15185
SE
Phone: +46.855326000
Email: domains@astrazeneca.com
Technical Contact:
Corporation Service Company
Domain Registrar
2711 Centerville Rd Suite 400
Wilmington, DE 19808
US
Phone: +1.3026365400
Email: admin@internationaladmin.com
DNS Servers:
dns2.cscdns.net
dns1.cscdns.net
Register your domain name at http://www.cscglobal.com
США - 198.155.190.132
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
HTTP/1.1 200 OK
Cache-Control: private
Content-Type: text/html
Server: Sanofi
LB_SERVER: 1
Content-Length: 16463
Date: Sat, 11 Jan 2020 00:23:26 GMT
Connection: keep-alive
Set-Cookie: ASPSESSIONIDCCSADCRA=FBABMKIAFGCBMIFPEOBAENAC; path=/
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"